New uses of lactic acid bacteria and bifidobacteria
作者： Didier Carcano , Sampo Lahtinen , Pierre Desreumaux , Rémy Burcelin
DOI:
关键词:
摘要: The invention comprises use of a bacterium selected from lactic acid bacterium, Bifidobacterium and mixture any thereof in the manufacture food product, dietary supplement or medicament for lowering tissue inflammation (in particular, adipose, liver muscle inflammation) treating cardiovascular disease mammal. bacteria and/or Bifidobacteria can also be used to treat diabetes insulin resistance induce enhanced secretion upon glucose challenge lower blood levels without concomitant decrease weight gain.
lens.org 参考文章(15)
Bernard Downs, Compositions for prevention and treatement of symptoms of gastrointestinal distress ,(2006)
Anne M. Birkett, Richard Le Leu, Graeme P. Young, Ian Lewis Brown, Probiotic/non-probiotic combinations ,(2007)
Michael Anthony Ceddia, Mark Alan Tetrick, Barry Pius Kiely, Robert Jason Vickers, Liam Diarmuid O'mahony, Gregory Dean Sunvold, Thomas William-Maxwell Boileau, Gary Mitchell Davenport, John Kevin Collins, Canine probiotic bifidobacteria pseudolongum ,(2004)
Gerald Christopher O'sullivan, Barry Kiely, Liam O'mahony, Fergus Shanahan, John Kevin Collins, A formulation comprising a bacterial strain ,(2004)
Hea Joung, Hang Kim, Han Park, Bong Kim, Young Bang, Microorganisms for treatment or prevention of corpulence and diabetes mellitus, and pharmaceutical composition containing the same ,(2003)
Arthur Constantijn Ouwehand, Marta Zdzislawa Korczynska, Wouter Herman Noordman, Probiotics for inducing satiety and/or satiation ,(2007)
Andrew R. Lefkowitz, Sean Farmer, Methods for reducing cholesterol using Bacillus coagulans spores, systems and compositions ,(1999)
Véronique Dennin, Gregory John Leyer, Sophie Nutten, Bruno Pot, Annick Mercenier, Bacterial composition and its use ,(2002)
Kirsi Laitinen, Seppo Salminen, Erika Isolauri, Supplemention of maternal diet ,(2008)
P. D. Cani, A. M. Neyrinck, F. Fava, C. Knauf, R. G. Burcelin, K. M. Tuohy, G. R. Gibson, N. M. Delzenne, Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. ,vol. 50, pp. 2374- 2383 ,(2007) , 10.1007/S00125-007-0791-0